Antibody responses in COVID-19: a review
M Chvatal-Medina, Y Mendez-Cortina… - Frontiers in …, 2021 - frontiersin.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread
worldwide as a severe pandemic. Although its seroprevalence is highly variable among …
worldwide as a severe pandemic. Although its seroprevalence is highly variable among …
Know your enemy or find your friend?—Induction of IgA at mucosal surfaces
M Bemark, D Angeletti - Immunological reviews, 2021 - Wiley Online Library
Most antibodies produced in the body are of the IgA class. The dominant cell population
producing them are plasma cells within the lamina propria of the gastrointestinal tract, but …
producing them are plasma cells within the lamina propria of the gastrointestinal tract, but …
Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans
A Haveri, N Ekström, A Solastie, C Virta… - European Journal of …, 2021 - Wiley Online Library
Most subjects develop antibodies to SARS‐CoV‐2 following infection. In order to estimate
the duration of immunity induced by SARS‐CoV‐2 it is important to understand for how long …
the duration of immunity induced by SARS‐CoV‐2 it is important to understand for how long …
Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals
Background The global pandemic of coronavirus disease 2019 (COVID-19) is caused by
infection with the SARS-CoV-2 virus. Currently, there are three approved vaccines against …
infection with the SARS-CoV-2 virus. Currently, there are three approved vaccines against …
Changes in anti-SARS-CoV-2 IgG subclasses over time and in association with disease severity
ZR Korobova, EV Zueva, NA Arsentieva, OK Batsunov… - Viruses, 2022 - mdpi.com
IgG is the most prominent marker of post-COVID-19 immunity. Not only does this subtype
mark the late stages of infection, but it also stays in the body for a timespan of at least 6 …
mark the late stages of infection, but it also stays in the body for a timespan of at least 6 …
Anti-SARS-CoV-2 immunoglobulin isotypes, and neutralization activity against viral variants, according to BNT162b2-vaccination and infection history
M Tarkowski, W de Jager, M Schiuma… - Frontiers in …, 2021 - frontiersin.org
Purpose To compare SARS-CoV-2 antigen-specific antibody production and plasma
neutralizing capacity against B. 1 wild-type-like strain, and Gamma/P. 1 and Delta/B. 1.617 …
neutralizing capacity against B. 1 wild-type-like strain, and Gamma/P. 1 and Delta/B. 1.617 …
Combined monitoring of IgG and IgA anti-Spike and anti-Receptor binding domain long term responses following BNT162b2 mRNA vaccination in Greek healthcare …
I Sarrigeorgiou, D Moschandreou, A Dimitriadis… - PLoS …, 2022 - journals.plos.org
Studies on the humoral response to homologous BNT162b2 mRNA-vaccination focus
mainly on IgG antibody dynamics, while long-term IgA kinetics are understudied. Herein …
mainly on IgG antibody dynamics, while long-term IgA kinetics are understudied. Herein …
The anti-SARS-CoV-2 IgG1 and IgG3 antibody isotypes with limited neutralizing capacity against omicron elicited in a Latin population a switch toward IgG4 after …
AM Espino, A Armina-Rodriguez, L Alvarez… - Viruses, 2024 - mdpi.com
The aim of this study was to analyze the profiles of IgG subclasses in COVID-19
convalescent Puerto Rican subjects and compare these profiles with those of non-infected …
convalescent Puerto Rican subjects and compare these profiles with those of non-infected …
Measurement of SARS-CoV-2 antibody titers improves the prediction accuracy of COVID-19 maximum severity by machine learning in non-vaccinated patients
M Kurano, H Ohmiya, Y Kishi, J Okada… - Frontiers in …, 2022 - frontiersin.org
Numerous studies have suggested that the titers of antibodies against SARS-CoV-2 are
associated with the COVID-19 severity, however, the types of antibodies associated with the …
associated with the COVID-19 severity, however, the types of antibodies associated with the …
Association of the serum levels of the nucleocapsid antigen of SARS-CoV-2 with the diagnosis, disease severity, and antibody titers in patients with COVID-19: a …
R Yokoyama, M Kurano, Y Nakano, Y Morita… - Frontiers in …, 2021 - frontiersin.org
Background: Several types of laboratory tests for COVID-19 have been established to date;
however, the clinical significance of the serum SARS-CoV-2 nucleocapsid (N) antigen levels …
however, the clinical significance of the serum SARS-CoV-2 nucleocapsid (N) antigen levels …